Skip to main content

Suicide survey in a London borough

About one million people worldwide die each year from suicide. Hence, strategies to reduce deaths from suicide are a key public health priority in many countries. A recent study by Dennis Ougrin and colleagues published in the Journal of Public Health aimed to collate relevant data from local and national sources, which will demonstrate the incidence of death from suicide and undetermined injury in the London Borough of Brent. The study also aimed to determine the characteristics of the subjects dying of suicide and undetermined injury in the locality and to identify what structures and processes are in place for recognizing, monitoring and sharing information about suicide between primary care, secondary care and public health.

The authors identified all deaths by suicides and open verdicts in the residents of Brent between February 2005 and February 2008. Health records of the identified subjects were analysed by two researchers. The annual rate of suicide in the study period was 6.8 per 100 000 inhabitants. Of the 54 cases of suicide in the , 45% had a psychiatric diagnosis and 18% were in current contact with mental health services. Hanging was the most frequent mode of suicide. Only 25% had seen their general practitioner within a month of suicide.

The study showed that a suicide survey is a feasible method of monitoring suicide, sharing data between key stakeholders and learning from the trends uncovered. The role for primary care in suicide prevention seems important but may be limited by an unexpectedly large proportion of the subjects not being in contact with primary care. In addition, the majority of the last primary care consultations were not for mental health problems This emphasizes the importance of wider societal initiative to improve suicide rates in addition to NHS interventions (e.g. reducing access to methods of suicide; and better employment, education and housing).


Popular posts from this blog

Improving discharge planning in NHS hospitals

Factors that need to be considered in discharge planning that have been identified in previous projects include:

Ensuring that discharge arrangements are discussed with patients, family members and carers; and that they are given a copy of the discharge summary.Adequate coordination between the hospital, community health services, general practices, and the providers of social care services.There is a follow-up after discharge of patients at high risk of complications or readmission - either in person or by telephone - to ensure that the discharge arrangements are working well. Medicines reconciliation is carried out. This is the process of verifying patient medication lists at a point-of-care transition, such as hospital discharge, to identify which medications have been added, discontinued, or changed from pre-admission medication lists.Ensuring that any outstanding test results at discharge are obtained and passed on to primary care teams; and ensuring there are clear arrangements …

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.40 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…

What impact will Brexit have on the UK's life sciences sector?

On Thursday 3 November 2016, I spoke at a seminar at the Imperial College Business School on the topic of the impact of Brexit on the UK's life sciences sector (the NHS, universities, and pharmaceutical and biomedical companies). I emphasised the important role played in the life sciences sector by EU-trained professionals and the need to ensure that the UK continued to attract highly-qualified professionals to work, for example, in our National Health Service. I also discussed the need to increase spending on research and development to ensure that the UK remained a world leader in the biomedical industry. The other speakers at the seminar were Andrew Lansley (former Secretary of State for Health) and Richard Phillips (Director of Healthcare Policy at the Association of British Healthcare industries). The event was chaired by Andrew Brown. A copy of my talk can be viewed on Slideshare.